Management of co-existent tuberculosis and lung cancer

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
James Chung-Man Ho, Chi-Chiu Leung

Abstract

Tuberculosis (TB) and lung cancer are important global health threats, each accounting for 1.6 million deaths yearly. The incidence of both conditions remains high in many developing countries, especially in East Asia. There is now epidemiologic evidence that pre-existing TB poses an increased lung cancer risk. The clinical diagnosis of co-existent TB and lung cancer relies on symptoms of infection, typical radiological features and microbiological confirmation, and remains a challenge in both early and late stage lung cancer. The presence of histological granulomatous inflammation in resected lung specimens is not exclusively indicative of TB. The widely accepted systemic chemotherapy and immunotherapy for treating lung cancer are highly relevant to the occurrence of TB and its management. This review addresses the clinical approach to the diagnosis and treatment of TB that co-exists with lung cancer.

References

Dec 26, 2001·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Y I KimJ G Im
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Nov 5, 2003·Clinical Lung Cancer·Santiago Ballaz, James L Mulshine
Mar 24, 2004·Integrative Cancer Therapies·C Murray Ardies
Jan 21, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Su-Ying LowDavid C E Ng
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Claire SiemesBruno H Ch Stricker
Feb 21, 2007·World Journal of Surgical Oncology·Saulius Cicenas, Vladislavas Vencevicius
Jun 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Javier O JuradoVerónica E García
Mar 31, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Daniel P Steinfort, Louis B Irving
Jun 13, 2009·International Journal of Cancer. Journal International Du Cancer·Hui-Ying LiangBao-Sen Zhou
Aug 8, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jann-Yuan WangUNKNOWN Tami Group
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Sep 9, 2009·Chest·Almerico Marruchella
Dec 15, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yang-Hao YuChih-Yi Chen
Jul 17, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·V MartinezF Boué
Sep 19, 2012·American Journal of Epidemiology·Darren R BrennerRayjean J Hung
Apr 12, 2013·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·C C LeungC M Tam
Jan 8, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nishitha ShettyKumar Prabhash
Mar 13, 2014·Current Opinion in Pulmonary Medicine·Mariza VorsterJamshed Bomanji
Jul 24, 2014·American Journal of Respiratory and Critical Care Medicine·Rachel DenholmAnn C Olsson
Sep 30, 2014·The New England Journal of Medicine·Alice T ShawA John Iafrate
Nov 14, 2014·The Cochrane Database of Systematic Reviews·Mia Schmidt-HansenMarta Roqué I Figuls
Dec 4, 2014·The New England Journal of Medicine·Benjamin J SolomonUNKNOWN PROFILE 1014 Investigators
Mar 27, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Evangelia SkouraJamshed Bomanji
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Dec 15, 2015·Annals of Nuclear Medicine·Sampanna Jung RayamajhiDheeraj Gupta
Jan 1, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Fei KangJing Wang
Apr 12, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Fatih YakarMustafa Erelel
Apr 26, 2016·The Thoracic and Cardiovascular Surgeon·Serdar EvmanTalha Dogruyol
Jul 18, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kohei FujitaTadashi Mio
Sep 21, 2016·Journal of Clinical Pathology·Rucha S DagaonkarAkash Verma
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Nov 22, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Thanyanan Reungwetwattana, Alex A Adjei
Feb 6, 2017·Microbiology Spectrum·Wendy Susan StevensKeertan Dheda
Apr 11, 2017·European Journal of Immunology·Lydia Dyck, Kingston H G Mills
Jun 7, 2017·The New England Journal of Medicine·Solange PetersUNKNOWN ALEX Trial Investigators
Oct 1, 2017·Experimental and Therapeutic Medicine·Shan LangJianxin Wang

❮ Previous
Next ❯

Citations

Apr 23, 2020·International Journal of Molecular Sciences·Ruben Mercado SantosWen Cai Zhang
Dec 4, 2020·World Journal of Clinical Cases·E-Nuo CuiXi-Ran Jiang
Feb 26, 2021·The American Journal of Medicine·Shuhei UchiyamaEiji Hiraoka
Oct 15, 2020·European Journal of Clinical Investigation·Lijun ZhengChao Cai
Jun 17, 2020·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Gloria Hj ChanRoss A Soo
Oct 3, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Chung-Shu LeeChung-Han Ho
Jan 26, 2022·Molecular Biology Reports·Swagata RoySatarupa Banerjee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.